Expediting Psychedelics Approvals In The US And Canada

By Kimberly Chew, Ana Dukic and Sabrina Ramkellawan · January 30, 2024, 5:59 PM EST

In recent years, a growing body of psychedelic clinical trials has emerged, concentrating on addressing pressing unmet needs in areas such as post-traumatic stress disorder, treatment-resistant depression, and substance use disorder,...

To view the full article, register now.